10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001144204-16-117698`
Period End Date	20160630
Filing Date	20160809
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	bpth-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 40 Cash Flow Statement 28

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$8.85M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$4.22M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$11.08M	USD	Point-in-time
Cash	`Cash`	$13.86M	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$560.00K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$579.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$179.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.28M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$9.59M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.08M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.00K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.00K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$72.00K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$51.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$72.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$51.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.49M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.41M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.09M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.01M	USD	Point-in-time
Total Assets	`Assets`	$10.76M	USD	Point-in-time
Total Assets	`Assets`	$7.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$54.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$123.00K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$883.00K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$690.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$937.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$813.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$937.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$813.00K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 6/30/16 and 12/31/15, respectively	`CommonStockValue`	$90.00K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 6/30/16 and 12/31/15, respectively	`CommonStockValue`	$90.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$35.11M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$35.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-25.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-29.19M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$9.82M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$6.33M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$10.76M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$7.14M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.16M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$564.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.19M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.21M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.35M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$757.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.61M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$567.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.81M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.51M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.94M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.13M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.94M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.81M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.51M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$10.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$10.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$5.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$4.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.50M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89,763.00	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89,763.00	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89,763.00	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89,763.00	shares	2 Qtrs

Cash Flow Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.50M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$80.00K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$80.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$21.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$21.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$184.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$318.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$541.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$19.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.10M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$153.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$130.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-124.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.63M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.78M	USD	2 Qtrs
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$-2.78M	USD	2 Qtrs
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$-4.63M	USD	2 Qtrs
Cash, beginning of period	`Cash`	$8.85M	USD	Point-in-time
Cash, beginning of period	`Cash`	$4.22M	USD	Point-in-time
Cash, beginning of period	`Cash`	$11.08M	USD	Point-in-time
Cash, beginning of period	`Cash`	$13.86M	USD	Point-in-time
Cash, end of period	`Cash`	$8.85M	USD	Point-in-time
Cash, end of period	`Cash`	$4.22M	USD	Point-in-time
Cash, end of period	`Cash`	$11.08M	USD	Point-in-time
Cash, end of period	`Cash`	$13.86M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.